The data in my submission, sir, is from Statistics Canada's industry-wide data in which companies are allocated to different sectors based on their dominant business. It would include all the revenues and profits from supermarkets that happen to sell some pharmaceuticals on the side, as well. In that regard, we see that, as noted in my submission, the quantity of sales in real terms has shrunk over the last two years of high prices. That would include their attempts to diversify into other products, whether it's pharmaceuticals, clothing or other things some of these chains are selling.
Now, I am also puzzled by the logic of that argument. As a consumer, I don't really care whether I was ripped off in aisle A with the produce, aisle C with the packaged food or aisle F, where they sell Tylenol and other over-the-counter pharmaceutical products. I don't see that argument helping them.
If anything, the breadth of these companies' dominance not just in one industry—food—but also in others further attests to concerns about the corporate power this oligopoly is able to assert.